Haleon PLC Logo

Haleon PLC

A global consumer healthcare company focused on improving everyday health.

HLN | IL

Overview

Corporate Details

ISIN(s):
GB00BMX86B70 (+2 more)
LEI:
549300PSB3WWEODCUP19
Country:
United Kingdom
Address:
BUILDING 5, FIRST FLOOR, THE HEIGHTS, KT13 0NY WEYBRIDGE

Description

Haleon PLC is a global consumer healthcare company focused on improving everyday health. The company develops and markets a portfolio of category-leading brands built on scientific innovation and trusted by consumers and healthcare professionals. Its product offerings span several key categories, including Oral Health, Pain Relief, Respiratory Health, and Vitamins, Minerals, and Supplements. Notable brands within its portfolio include Sensodyne, Advil, Voltaren, and Centrum. Haleon's mission is to deliver better everyday health with humanity, making it more achievable, inclusive, and sustainable.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-15 11:10
Board and Committee Changes
English 12.2 KB
2025-12-10 16:25
Director/PDMR Shareholding
English 37.9 KB
2025-12-01 11:40
Total Voting Rights and Capital
English 7.8 KB
2025-11-12 12:10
Director/PDMR Shareholding
English 38.0 KB
2025-11-10 08:25
Appointment of Vindi Banga as Chair
English 15.0 KB
2025-11-03 12:40
Total Voting Rights and Capital
English 7.8 KB
2025-10-30 08:10
Haleon 2025 Q3 Trading Statement
English 410.9 KB
2025-10-30 08:00
Haleon 2025 Q3 Trading Statement
English 14.7 KB
2025-10-10 13:45
Director/PDMR Shareholding
English 39.5 KB
2025-10-02 11:05
Director Declaration
English 6.9 KB
2025-10-02 08:00
Transaction in Own Shares & Buyback Update
English 19.2 KB
2025-10-01 11:00
Total Voting Rights and Capital
English 8.1 KB
2025-10-01 08:00
Transaction in Own Shares
English 18.0 KB
2025-09-29 08:00
Transaction in Own Shares
English 17.9 KB
2025-09-26 14:30
Director/PDMR Shareholding
English 115.8 KB

Automate Your Workflow. Get a real-time feed of all Haleon PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Haleon PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Haleon PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.